Main > HEMATOLOGY > USA. A. PNH>Treat.>C3 Complement>
USA. A. PNH>Treat.>C3 Complement>'s subsections
(*) EU CE Mark Date: 2021. 12.15
(*) USA Approval Date: 2021. 05.14
>MAb Inj.
Company
Company Licensee EU
Generic Name: Pegcetaciplan
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2021. 12.14
PR Web-Site (EU)
Product Web-Site (USA)
RTM (EU)
USA. A. PNH>Treat.>C3 Complement>'s products
This section has no products